Drug Safety Alerts and Recalls

Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Drug Safety Alerts and Recalls

SAFETY ALERT: Risk of Cardiovascular Death with Zithromax

May 18, 2012

The FDA is notifying healthcare professionals of a new study reporting a small increase in cardiovascular death, and in the risk of death from any cause, in patients treated with a 5-day course of azithromycin (Zithromax; Pfizer) compared to persons treated with amoxicillin, ciprofloxacin, or no drug.

RECALL: Hydromorphone HCl Injection 1mg/mL Recall

May 14, 2012

Hospira has notified healthcare professionals of a recall of one lot of Hydromorphone HCl Injection 1mg/mL due to reports of a single Carpuject containing more than the 1mL labeled fill volume.

SAFETY ALERT: New Malignancy Risk with Revlimid

May 08, 2012

The FDA notified the public of an increased risk of second primary malignancies in patients with newly-diagnosed multiple myeloma who received Revlimid (lenalidomide capsules; Celgene).

RECALL: Franck's Compounding Triamcinolone Acetonide Recall

May 04, 2012

Franck's Compounding Pharmacy has recalled one additional lot of triamcinolone acetonide PF 80mg/mL.

SAFETY ALERT: Drug Interactions with Victrelis and Ritonavir-Boosted Protease Inhibitors

April 26, 2012

The FDA has notified healthcare professionals that drug interactions between the hepatitis C virus (HCV) protease inhibitor Victrelis (boceprevir; Merck) and certain ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors can potentially reduce the effectiveness of these medicines when they are used together.

RECALL: Epinephrine Injection 1:1000 Ampules Recall

April 25, 2012

American Regent is conducting a nationwide voluntary recall of Epinephrine Injection, 1:1000, 1mL ampules (NDC #0517-1071-25; Lot #1395; Exp Date: July 2012).

Gilenya Prescribing Information Update

April 20, 2012

Novartis has updated the prescribing information for Gilenya (fingolimod), a once daily oral therapy indicated to reduce the number of relapses and slow disability progression in patients with relapsing forms of multiple sclerosis (MS), to include updated patient selection parameters based on certain cardiovascular considerations.

SAFETY ALERT: New Warning and Contraindication for Aliskiren

April 20, 2012

The FDA has notified healthcare professionals of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in patients with diabetes or renal impairment.

SAFETY ALERT: Second Warning for Franck's Compounds

April 20, 2012

The FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G (BBG) during eye surgery since the FDA Warning to Physicians was posted on March 19, 2012.

RECALL: Morphine Sulfate 4mg/mL Carpuject Recall

April 18, 2012

Hospira announced a nationwide voluntary recall of one lot of Morphine Sulfate injection, 4mg/mL, due to a customer report of two Carpujects syringes containing more than the 1mL labeled fill volume.